773 related articles for article (PubMed ID: 19389452)
1. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
Shim E; Galvani AP
Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
Wu CL; Yang YC; Huang LM; Chen KT
Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
[TBL] [Abstract][Full Text] [Related]
4. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
[TBL] [Abstract][Full Text] [Related]
6. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
[TBL] [Abstract][Full Text] [Related]
8. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of rotavirus vaccination in Australia.
Newall AT; Beutels P; Macartney K; Wood J; MacIntyre CR
Vaccine; 2007 Dec; 25(52):8851-60. PubMed ID: 18022735
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of rotavirus vaccination in Italy.
Giammanco MD; Coniglio MA; Pignato S; Giammanco G
Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
12. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
[TBL] [Abstract][Full Text] [Related]
14. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
Bilcke J; Van Damme P; Beutels P
Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433
[TBL] [Abstract][Full Text] [Related]
16. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?
Mangen MJ; van Duynhoven YT; Vennema H; van Pelt W; Havelaar AH; de Melker HE
Vaccine; 2010 Mar; 28(14):2624-35. PubMed ID: 20109593
[TBL] [Abstract][Full Text] [Related]
17. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands.
Goossens LM; Standaert B; Hartwig N; Hövels AM; Al MJ
Vaccine; 2008 Feb; 26(8):1118-27. PubMed ID: 18215445
[TBL] [Abstract][Full Text] [Related]
18. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.
Jit M; Edmunds WJ
Vaccine; 2007 May; 25(20):3971-9. PubMed ID: 17400341
[TBL] [Abstract][Full Text] [Related]
19. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
[TBL] [Abstract][Full Text] [Related]
20. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
